Stockreport

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial

Monopar Therapeutics Inc.  (MNPR) 
PDF WILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative [Read more]